Joint Perfusion Covid-19 Task Force Webinar Available

Rationale and Practical use of CytoSorb, an Extracorporeal Cytokine Adsorber, with ECMO to Treat Cytokine Storm in Critically-Ill COVID-19 patients

Speakers and topics:
“CytoSorb and ECMO: A Novel “Lung Resting” Strategy in Critically-Ill COVID-19 patients under FDA Emergency Use Authorization”
Dr. Phillip Chan, MD, PhD, CEO CytoSorbents Corporation 

“Practical Experience in Treatment of COVID-19 Patients in Combination with ECMO and CytoSorb”
Mr. Stefan Sajgo, Ulm University, Ulm Germany

Friday October 9, 2020 Duration: 1.5 hours

Please click here to view